The SPDR® S&P® Biotech ETF, before expenses, seeks to closely match the returns and characteristics of the S&P Biotechnology Select IndustryTM Index.
Ordinary brokerage commissions may apply.
|Primary Benchmark||S&P Biotechnology Select Industry Index|
|Short Selling Allowed||Yes|
|Gross Expense Ratio||0.35%|
|Investment Manager||SSgA Funds Management, Inc.|
|Management Team||ETF Management Team|
|Distributor||State Street Global Markets, LLC|
|Exchange||NYSE ARCA EXCHANGE|
|Variable Fee for Cash Creation||.75%|
|Variable Fee for Cash Redemption||.75%|
|Est. 3-5 Year EPS Growth||21.48%|
|FY 1 P/E Ratio||30.35|
|Number of Holdings||71|
|Weighted Average Market Cap||$8,884.40 M|
|30 Day SEC Yield||1.03%|
|Est. 3-5 Year EPS Growth||22.32%|
|FY 1 P/E Ratio||30.51|
|Number of Holdings||69|
|Return On Equity||-76.14%|
As of 02/28/2014
As of 12/31/2013
Performance quoted represents past performance, which is no guarantee of future results. Investment return and principal value will fluctuate, so you may have a gain or loss when shares are sold. Current performance may be higher or lower than that quoted.
|Exchange Volume (shares)||503,462|
|Shares Outstanding||8.90 M|
|Total Net Assets||$1,431.49 M|
|Net Cash Amount||$3,559,189.30|
|Weighted Average Market Cap||$8,661.51 M|
Buying and Selling ETFs
ETFs are flexible and easy to trade. Investors buy and sell them like stocks, typically through a brokerage account. Investors can also employ traditional stock trading techniques; including stop orders, limit orders, margin purchases, and short sales using ETFs. They are listed on major US Stock Exchanges.
ETFs are subject to risk similar to those of stocks including those regarding short-selling and margin account maintenance.
Ordinary brokerage commissions apply.
After-tax returns are calculated based on NAV using the historical highest individual federal marginal income tax rates and do not reflect the impact of state and local taxes. Actual after-tax returns depend on the investor's tax situation and may differ from those shown. The after-tax returns shown are not relevant to investors who hold their fund shares through tax-deferred arrangements such as 401(k) plans or individual retirement accounts.
Performance of an index is not illustrative of any particular investment. It is not possible to invest directly in an index.
Unless Otherwise noted all information contained herein is that of the SPDR S&P Biotech ETF.
The S&P Select Industry series is designed to measure the performance of narrow GICS (Global Industry Classification Standard) sub-industries. The S&P Biotechnology Select Industry Index is an equal-weighted index that draws constituents from the GICS Biotechnology sub-industry. Liquidity and market capitalization screens are applied to the index to ensure investability.
As with all stocks, you may be required to deposit more money or securities into your margin account if the equity, including the amount attributable to your ETF shares, declines.
Because of their narrow focus, sector funds tend to be more volatile than funds that diversify across many sectors and companies.